---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-014925"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2025-09-25T23:59:59+00:00"
generated_at: "2026-05-17T05:44:34.386728+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health amends securities purchase agreement; grants board seats, fixes warrant exercise price at $0.35

## Summary
- Amendment requires Aspira to file Form S-1 by Sept 30, 2025 to register shares and warrant shares.
- Purchasers (existing accredited shareholders) gain right to appoint 3 directors until earlier of 3 years or 50% warrant threshold.
- Warrants amended: fixed exercise price $0.35, cash-only exercise, 6-year term, exercisable after 6 months.
- Exempt Issuance definition modified to exclude firm commitment or at-the-market offerings.

## SEC filing metadata
- accession: 0001493152-25-014925
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2025-09-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000149315225014925/0001493152-25-014925-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000149315225014925/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-014925
- JSON: https://secwatch.observer/filing/0001493152-25-014925.json
- Plain text: https://secwatch.observer/filing/0001493152-25-014925.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.